Histogenics Corporation to Present at Cowen and Company 35th Annual Health Care Conference
February 23, 2015 10:07 ET
|
Histogenics Corporation
WALTHAM, Mass., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation to Announce Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015
February 12, 2015 16:05 ET
|
Histogenics Corporation
WALTHAM, Mass., Feb. 12, 2015 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the...
Histogenics Corporation Announces the Appointment of David Gill to Its Board of Directors and Chairman of Audit Committee
February 02, 2015 16:05 ET
|
Histogenics Corporation
WALTHAM, Mass., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space,...
Histogenics Corporation Announces Pricing of Initial Public Offering
December 02, 2014 18:46 ET
|
Histogenics Corporation
WALTHAM, Mass., Dec. 2, 2014 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space,...